IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer

NCT05827796 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: IN10018
DRUG: Albumin-Bound Paclitaxel
DRUG: Gemcitabine
DRUG: KN046

Sponsor

InxMed (Shanghai) Co., Ltd.